Events & Presentations

Ablynx organises webcasts for analysts and investors on the occasion of financial results publications and product specific news. In addition, the Company’s presentations at investor conferences are often webcasted and made available for the broader public.

Upcoming IR Events

UBS Global Healthcare Conference
22-24 May 2017 - New York, USA

Jefferies 2017 Global Healthcare Conference
6-9 June 2017 - New York, USA

Lynx Belgian Biotech Congress
17 June 2017 - Gent, Belgium

Recent IR Presentations

Ablynx's 2016 full year results webcast
23 February 2017

Click here to replay the webcast

pdf version of the presentation

J.P. Morgan 35th Annual Healthcare Conference 2017
9-13 January 2017 - San Francisco (CA), USA

Click here to replay the webcast

pdf version of the presentation

Webcast presentatie - vobarilizumab, a novel best-in-class anti-IL-6R drug candidate for the treatment of RA
20 oktober 2016

Click here to replay the webcast

pdf version of the presentation

Upcoming Scientific Events

10th Annual Proteins & Antibodies Congress 2017
24-25 April 2017 - London, UK

Cell Line Development & Engineering Congress
24-26 April 2017 - Amsterdam, The Netherlands

Recent Scientific Presentations

Poster "Impact of caplacizumab treatment on mortality and major thromboembolic events in acquired TTP: Phase II TITAN study results" presented at the 21st European Hemathology Association Congress
9 June 2016 - Copenhagen, Denmark

pdf version of the presentation

Nanobodies as a Versatile Approach for Developing Next Generation Immunotherapies
26 January 2016 - Washington (DC), USA

pdf version of the presentation

Shareholders' Clubs

Individual investors can meet with the Ablynx management team at Ablynx’s Quarterly Shareholders’ Clubs organised at Ablynx.

The next events in Dutch will take place on:

24 May 2017 at 5.30pm
13 September 2017 at 5.30pm
6 December 2017 at 5.30pm

To attend an event, please register via email:, mentioning your name and preferred day.

Please click here to download the presentation of the most recent shareholders' club.